Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial

INTRODUCTION: Non-cystic fibrosis bronchiectasis (NCFB) brought a heavy healthcare burden worldwide. Macrolide maintenance therapy was proved to be helpful in reducing exacerbation of NCFB. However, the optimal dosing regimens of macrolides have not been determined, and its efficacy in Chinese NCFB...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yanxiong, Chen, Lan, He, Ting, Li, Jing, Zou, Aiping, Li, Feng, Chen, Fei, Fan, Bo, Ni, Weihao, Xiao, Wei, You, Huimin, Fu, Wenjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272127/
https://www.ncbi.nlm.nih.gov/pubmed/35803624
http://dx.doi.org/10.1136/bmjopen-2021-059186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272127/
https://www.ncbi.nlm.nih.gov/pubmed/35803624
http://dx.doi.org/10.1136/bmjopen-2021-059186

Ejemplares similares